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ABSTRACT 
Background: Hyperferritinemia-cataract syndrome (HCS) is a rare Mendelian 
condition characterized by bilateral cataract and high levels of serum ferritin in the 
absence of iron overload.  
Methods: HCS was diagnosed in three adult siblings. In two of them it was possible 
to assess lens changes initially in 1995 and again in 2013. Serum ferritin, iron, 
transferrin concentrations and transferrin saturation percentage were also measured 
and the Iron Responsive Element (IRE) region of the L-Ferritin gene (FTL) was 
studied. 
Results: Serum ferritin concentrations were considerably elevated while serum iron, 
transferrin and transferrin saturation levels were within the normal range in each 
sibling. Cataract changes in our patients were consistent with those previously 
reported in the literature. Progression of the cataract, an aspect of few studies in this 
syndrome, appeared to be quite limited in extent. The heterozygous +32G to T (-
168G>T) substitution in the IRE of the FTL gene was detected in this family. 
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Conclusions: Ophthalmic and biochemical studies together with genetic testing 
confirmed HCS in three family members. Although the disorder has been extensively 
described in recent years, little is known regarding cataract evolution with time. In 
our cases, lens evaluations encompassed many years, identified bilateral cataract of 
typical morphology and supported the hypothesis that this unique clinical feature of 
the disease tends to be slowly progressive in nature, at least in adults.  
 
 
 
 
Key words: cataract, hyperferritinemia-cataract syndrome, iron responsive element, 
L-ferritin gene. 
 
 
 
 
 
 
Introduction 
Hyperferritinemia-cataract syndrome (HHCS; OMIM #600886) is a rare autosomal 
dominant condition first described in 1995 by two different groups as a disorder 
characterized by bilateral congenital cataract and hyperferritinemia in the absence of 
iron overload disease1,2. High levels of serum ferritin are constantly detected, usually 
varying between 700 and 2000 µg/L (upper normal limit 200 µg/L in adult females 
and 300 µg/L in adult males) and are not accompanied by increased body iron 
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stores. Therefore, serum iron and transferrin saturation are usually normal in these 
patients. HCS is caused by a peculiar mechanism that is independent from iron 
metabolism but involves a loss of the normal regulation of L-Ferritin gene (FTL) 
expression and, consequently, uncontrolled synthesis of the L-Ferritin polypeptide. 
Bilateral cataract changes are revealed representing unique organ damage in this 
disease. They consist of nuclear and cortical opacities1, 3 and white vacuolar deposits 
developing to dust-like “pulverulent” spots in all layers of both lenses2. The use of the 
term pulverulent should not lead to confusion with the central pulverulent or Coppock 
cataract about which there is an abundant literature since Nettleship’s original 
description in 19064. Considerable variations have been described. Its features 
appear to be highly distinctive and consistent in appearance and are primarily 
characterized by axial and peripheral white dots and flecks and distinctive crystalline 
aggregates3. The effect on vision depends on the extent of the cataract but also on 
the local distribution of cortical and nuclear opacities5.  As a result, visual acuity may 
only be slightly reduced and lens extraction is not always necessary. Glare in bright 
sunlight as well as in nocturnal conditions may be an issue6.  
The pathogenesis of cataract formation in HCS is not completely understood. One 
possible hypothesis suggests that crystalline deposition of L-Ferritin itself may result 
in cataract development7,8. Otherwise, enhanced L-Ferritin in the lens could alter the 
solubility of other lens proteins causing the formation of complex deposits9. Kroger et 
al.10 stated that the opacities consisted of abundant L-Ferritin protein. 
As far as is known, bilateral cataract is the only clinical manifestation of this 
disorder6. Lens opacities were at first thought to be always bilateral and 
congenital11,12 but after the observations by Girelli and collaborators13 of an 
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obligatorily affected new-born patient that was free of lens changes at birth and again 
at one year of age, it was clear that the cataract probably becomes manifest during 
postnatal life and developes in early infancy. In addition, progression of the cataract 
seems to be slow, but only a few longitudinal studies by serial lens photography have 
documented its evolution over time3,14. Therefore, further multiple serial ophthalmic 
observations in patients known to be affected by HCS, particularly in preclinical 
stages, should clarify these fundamental aspects of the disease.  
The presence of bilateral cataract together with increased serum ferritin levels 
without iron overload disease are the clinical criteria needed for the diagnosis of 
HCS6 but the disease should be suspected by optometrists and ophthalmologists in 
a patient of any age with bilateral cataract showing a distinctive pattern. Molecular 
studies can confirm the diagnosis in all cases. 
Genetic background 
HCS is caused by mutations, most often in the heterozygous condition, in the iron-
responsive-element (IRE) of the FTL gene, encoding L-Ferritin and located on 
chromosome 19q13.315.  IREs are short conserved structures present in the mRNAs 
of several genes involved in iron metabolism and are composed of a hexanucleotide 
apical loop and a stem interrupted by a small asymmetrical bulge16,17. Ferritin IRE 
regulates ferritin synthesis in relation to the intracellular content of iron by means of 
its interaction with iron regulatory proteins (IRPs)18,19 that are able to block the 
translation of the L-Ferritin polypeptide. Heterozygous mutations in the IRE region of 
FTL IRPs distort the loop structure of FTL IRE which reduces or abolishes its binding 
with IRPs. As a consequence, an unregulated production of L-Ferritin, independent 
or irrespective of iron stores, occurs.  
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Presently, about 40 mutations throughout the FTL IRE have been found worldwide5 
and, as previously demonstrated, there exists a correlation between the position of 
the mutation, ferritin levels and the extent of lens changes in this disease11. Patients 
with mutations in the highly conserved hexanucleotide region or the bulge area seem 
to show higher serum ferritin and more severe cataract compared to those 
individuals with a mutation of the upper or lower stem11,20. At the same time, it is 
believed that factors independent of the mutation and serum ferritin levels are 
involved in the timing of onset and severity of the cataract. 
In order to provide additional information regarding the features and evolution of lens 
opacities in HCS, we report on three siblings affected by the disease and describe 
the ophthalmic observations occurring over a long period. 
 
Case Report 
The index case (Figure 1, III 6) is a 37 year-old white Italian female. She initially 
consulted one of us (FZ) in 1995. She was a high myope and wanted to be assessed 
for contact lenses. Her ocular history was notable for the early onset of cataract, 
diagnosed at the age of six. Two of her older brothers were also aware they had 
cataract, diagnosed at age 31 (III 4) and 20 (III 5). Their late father (II 4) knew of his 
own cataract since his daughter was very young. The index case’s first cousin (III 2) 
had cataract extraction at the age of 30 and it is known that her father and late aunt 
(II 1 and II 2) also had cataract. In the three siblings with cataract, high contrast 
visual acuity and low contrast visual acuity were measured at six metres using an 
LCD Optotype (CSO: Florence, Italy) generating a five letter row of Sloan letters. 
Scores were determined using a letter-by-letter criterion. The weight of each letter 
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was 0.02 logarithm of the minimum angle of resolution. The cataract was examined 
with the slit-lamp biomicroscope through dilated pupils. When the patient became 
pregnant in 2012, routine blood tests revealed she had hyperferritinemia. She was 
informed that her condition might be inherited and she and her brothers were 
genetically tested. 
After obtaining informed consent, serum ferritin, iron, transferrin concentrations and 
transferrin saturation percentage were measured by the usual procedures. DNA was 
extracted from peripheral blood by the use of a standard protocol. The entire IRE 
region of FTL was then sequenced in both directions using the ABI PRISM BigDye 
Terminator Cycle Sequencing kit on an Applied Biosystem 3500xL sequencer.  
Refraction and high and low contrast visual acuity data are given in Table 1. Our 
patients had very similar lens changes, these being a combination of more central 
larger crystalline-like opacities and smaller peripheral fleck and punctate opacities. 
Additionally, many of the peripheral opacities were blue in colour, reminiscent of the 
blue-dot, punctate or cerulean cataract but of an entirely different aetiology21. One of 
the siblings (III 5) also had small blue punctate opacities near his right posterior Y 
suture. In both brothers, retroillumination from the fundus through dilated pupils 
showed opacities occupying the suture lines and assuming star-shaped figures 
(Figure 2).  
Photographs of the cataract of the index patient and one of her brothers (III 5) were 
taken for the first time in 1995 and we have compared them with the most recent 
photographs taken in 2013, (Figures 3 and 4). There appears to have been few 
changes in the shape and number of opacities. High contrast visual acuity in our 
patients was generally good. One brother (III 5) had poorer acuity in his left eye due 
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to macular changes of undetermined cause. All patients had minor problems with 
glare from time to time. Low contrast visual acuity was worse in each sibling and the 
deleterious effect of cataract on contrast sensitivity and glare disability is well 
known22. 
Serum ferritin concentration was considerably elevated in the index case with values 
varying from 1853 to 2189 µg/L (normal range <200 µg/L). Serum iron, transferrin 
and transferrin saturation levels were within the normal range (Table 1). Two of her 
brothers (III 4 and III 5) also had high levels of serum ferritin, these being 1400 to 
2021 µg/L and 1000 to 1200 µg/L respectively (normal range <300 µg/L) (Table 1). 
Again, serum iron, transferrin and transferrin saturation were normal. A third brother 
(III 3) had normal blood levels of ferritin. 
Genetic testing confirmed that the index case and two of her brothers had HCS since 
FTL IRE direct sequencing showed the same heterozygous +32G to T (-168G>T) 
substitution (Figure 5). The c.-168G>T mutation, localized in the asymmetric bulge of 
the IRE structure, is well known in the literature3, 23, 24. The index patient gave birth to 
a son (IV 2). There was a 50% chance that the child would have HCS. However, he 
was found to be free of cataract and had not inherited the +32G to T FTL mutation. 
 
Discussion 
HCS is inherited as an autosomal dominant trait1,2 and is considered to be very rare, 
although it is probably underdiagnosed. This report illustrates that the disorder can 
remain unrecognized. The diagnosis was made for the first time in the index case at 
37 years of age and it is reasonable to speculate that many family members from 
multiple generations were affected by the disease. The distinguishing features of the 
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cataract in the presence of a positive family history should raise suspicion of the 
disease. 
In our patients, lens findings appeared to be consistent with those already described. 
In addition, we documented that many of the peripheral opacities were blue in colour, 
resembling blue-dot, punctate or cerulean cataract, a type of cataract that can be 
due to mutations in genes that encode various lens crystallins21.25. As far as we 
know, there are no other reports describing such a finding in HCS.  
 
Slit-lamp photographs enabled us to investigate the degree of progression of the 
cataracts over an 18 year period in two of the three siblings, even though the image 
support is different (analogue versus digital), and the older images being film have 
lost quality. It is possible to say that in terms of the shape and number of opacities, 
the cataract appears to have changed little over a long period of time (Figures 3 and 
4). In terms of the overall degree of opacification, it is not possible to state that there 
has not been any change with absolute certainty. However, slit-lamp observations 
were able to document the absence of a clear worsening of lens changes during 
adulthood in our HCS patients.  
In addition to early onset cataract, the index patient and her brothers showed high 
levels of serum ferritin but, at the same time, other biochemical iron overload serum 
indexes were in the range of normal values. In line with recent recommendations, we 
therefore could easily exclude the presence of iron overload and, consequently, the 
principal forms of hereditary haemochromatosis 26,27. 
Molecular studies revealed a c-168 G>T (+32G>T) mutation in all three siblings. The 
mutated nucleotide was localized in the asymmetrical bulge of the IRE structure of 
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the FTL gene. The mutation has been previously associated with serum levels 
ranging from 950 to 1900 µg/L, with defects in visual acuity that were about the same 
as in our cases11 and with cataract that can be already detected at the age of 18 
months28. Even if we could not assess when lens changes first appeared in our 
patients, we are aware that at the age of six, cataract was diagnosed in the index 
case, and this leads us to suppose that it mainly developed during childhood. 
Moreover, biochemical and ophthalmic findings in the affected siblings lacked inter-
individual variability, supporting the assumption that a correlation does exist between 
the FLT IRE mutation and phenotypic expressivity. 
 
Conclusions 
Ophthalmic examination and genetic testing showed that three adult family members 
had HCS. Clinical features were very similar in the three sibling patients. It is 
reasonable to believe that progression of the cataract was minimal over time during 
adulthood. We think it is possible to assume that its formation occurred 
predominantly during childhood and then slowly progressed. Many other longitudinal 
studies are needed to verify this hypothesis and to assess whether our observations 
are common to other patients with HCS due to the +32G to T (-168G>T) or to 
different mutations in the IRE of FTL. 
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Figures Legend 
 
Figure 1. Family pedigree. 
Figure 2. Left cataract of subject III.4. 
Figure 3: case III 6. Left cataract in 1995 (a) and in 2013 (b) respectively.  
Figure 4. case III 4. Right cataract in 1995 (a) and in 2013 (b) respectively.  
Figure 5: Schematic representation of the FTL IRE structure and location of the point 
mutation identified in the present study.  
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Figure 1. Family pedigree.
Family history of cataract; Individuals with confirmed diagnosis of hyperferritinemia-cataract syndrome;
Deceased; Index case;
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Table 1. Biochemical parameters, refraction, visual acuity, genotype and age of diagnosis of cataract in the subjects with HCS 
Family Sex 
Age at cataract 
diagnosis 
Age at genetic exam Refraction 
High contrast 
VA* 
(logMAR) 
Low contrast 
VA* 
(logMAR) 
Serum ferritin 
(Range) 
Serum Iron 
Serum 
transferrin 
TS%° 
III-6 F 6 37 R -12.00 / -2.00 x 10 0.22 0.66 1853-2189µg/L 36 224 11 
   L-11.50 / -1.50 x 170 0.16 0.60     
 
 
         
III-5 M 20 46 R +0.75 / -2.25 x 160 0.12 0.54 1000-1200µg/L 131 230 40 
   L+0.75 / -2.00 x 25 0.34 0.90     
           
III-4 M 31 47 R +1.00 /  -2.25 x 175 0.14 0.48 1450-2120µg/L 81 245 23 
   L+0.50 / -2.25 x 180 0.10 0.34     
*VA= visual acuity; °TS% = transferrin saturation percentage. Normal values: serum ferritin:11-200µg/L (female), 24-300µg/L (male); serum iron: 60-140µg/dL (female), 80-170µg/dL (male); serum 
transferrin: 200-400mg/dL: TF%: 18-45. 
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